Giacomo , - you are right , but according to Dr P
Post# of 148112
only about 20% of tumors ( cancers ) cells are CCR5 positive ,
but IF macrophages around the tumors are CCR5 positive ..( majority of patients )..., cancer should respond to Leronlimab..( and probably to some other CCR5 inhibitors )...